corona virus

The purpose of this article on COVID-19 is to aggregate existing research, bring together the relevant data and allow readers to make sense of the published data and early research on the coronavirus outbreak.

Limitations of current research and data, and limitations of our reporting on current knowledge

Most of our work focuses on established problems, for which we can refer to well-established research and data. 

COVID-19 is different. All data and research on the virus is preliminary; researchers are rapidly learning more about a new and evolving problem. It is certain that the research we present here will be revised in the future. But based on our mission we feel it is our role to present clearly what the current research and data tells us about this emerging problem and especially to provide an understanding of what can and cannot be said based on this available knowledge.

As always in our work, one important strategy of dealing with this problem is to always link to the underlying original research and data so that everyone can understand how we arrive at the statements we make. But scrutiny of all reported research and data is very much required. We welcome your feedback.

“Tasty food, set inside a lovely coffee house.”

It was an real incredible experience for me. The quality of food was only matched by the quality of service I got. I wish I can keep the flavor in my mouth for ever. Thanks for making the evening an unforgettable one.
Sandra Files

Tasty Breakfast

Five new countries/territories/areas (Jersey, Réunion, Saint Vincent and the
Grenadines, Cuba and Guyana) have reported cases of COVID-19 in the past
24 hours.
• The WHO, UN Foundation and partners launched a first-of-its-kind COVID-19
Solidarity Response Fund today. The fund will raise money from a wide range
of donors to support the work of the WHO and partners to help countries
respond to the COVID-19 pandemic. For more details, please see here.
• Since the onset of the COVID-19 outbreak, Infection Prevention and Control
(IPC) has been a major factor in preventive and mitigation measures. To ensure
evidence-based quality guidance and prompt response to global demand,
WHO convened a WHO Health Emergencies Programme Experts Advisory
Panel for IPC. For more information, please see ‘subject in focus’.
• A team of experts from WHO, Global Outbreak Alert and Response Network
partners, the Robert Koch Institute in Germany and the Chinese Center for
Disease Control concluded a technical support mission on COVID-19 to Iran on
10 March 2020. During the team’s mission in Iran, the Ministry of Health and
Medical Education (MOHME) launched a national campaign to control COVID19. For more information on the mission, please see here.
Figure 1. Countries, territories or areas with reported confirmed cases of COVID-19, 13 March 2020
SUBJECT IN FOCUS: Infection Prevention and Control (IPC) – update
Since the onset of the COVID-19 outbreak, IPC has played a major role in preventive and mitigation measures. To
ensure evidence-based quality guidance and prompt response to global demand, WHO convened a WHO Health
Emergencies (WHE) Programme Ad-Hoc Experts Advisory Panel for Infection Prevention and Control, which is attended
by members of the Global Infection Prevention and Control Network (GIPCN), members of relevant institutions, and
Member States affected by COVID-19. This advisory panel supports the WHE IPC pillar with timely advice on
preparedness, readiness and response to COVID-19 based on evidence where available. They hold weekly discussions
on the technical aspects of IPC measures, and shared experiences across affected countries. The following
guidance/tools have been issued, in consultation with this global IPC advisory panel:
1. Health workers exposure risk assessment and management in the context of COVID-19 virus. This tool is to
be used by health care facilities that have either cared for or admitted COVID-19 patients; it is to be
completed for all health care workers (HCW) who have been exposed to a confirmed COVID-19 patient in a
health care facility. It helps determine the risk of COVID-19 virus infection of the HCW who have been
exposed to a COVID-19 patient and provides recommendations for appropriate management of these HCWs,
according to their infection risk.
2. Considerations for quarantine of individuals in the context of containment for coronavirus disease (COVID19) The purpose of this document is to offer guidance to Member States on quarantine measures for
individuals in the context of COVID-19. It is intended for those responsible for establishing local or national
policy for quarantine of individuals, and adherence to infection prevention and control measures in these
settings.
3. In collaboration with WASH colleagues including UNICEF, the team has developed a briefing on water,
sanitation, hygiene and waste management for COVID-19. More information can be found here.
WHO IPC specialists are currently supporting a number of countries and have been deployed to support the response
in cooperation with IPC teams in Italy and Iraq, amongst other countries.
The online course “Infection Prevention and Control (IPC) for COVID-19” has been translated into Russian and
Japanese. As of 13 March, 38 725 people have registered for the course. Infographics, including videos (e.g. when and
how to use a mask), are being developed on demand,
To support the preparedness, readiness and response for COVID-19, WHO has convened teleconferences in
cooperation with other partners, including with Africa CDC/CDC/ECHO and with the World Organization of Family

NO Birthdays & Events

Five new countries/territories/areas (Jersey, Réunion, Saint Vincent and the
Grenadines, Cuba and Guyana) have reported cases of COVID-19 in the past
24 hours.
• The WHO, UN Foundation and partners launched a first-of-its-kind COVID-19
Solidarity Response Fund today. The fund will raise money from a wide range
of donors to support the work of the WHO and partners to help countries
respond to the COVID-19 pandemic. For more details, please see here.
• Since the onset of the COVID-19 outbreak, Infection Prevention and Control
(IPC) has been a major factor in preventive and mitigation measures. To ensure
evidence-based quality guidance and prompt response to global demand,
WHO convened a WHO Health Emergencies Programme Experts Advisory
Panel for IPC. For more information, please see ‘subject in focus’.
• A team of experts from WHO, Global Outbreak Alert and Response Network
partners, the Robert Koch Institute in Germany and the Chinese Center for
Disease Control concluded a technical support mission on COVID-19 to Iran on
10 March 2020. During the team’s mission in Iran, the Ministry of Health and
Medical Education (MOHME) launched a national campaign to control COVID19. For more information on the mission, please see here.
Figure 1. Countries, territories or areas with reported confirmed cases of COVID-19, 13 March 2020
SUBJECT IN FOCUS: Infection Prevention and Control (IPC) – update
Since the onset of the COVID-19 outbreak, IPC has played a major role in preventive and mitigation measures. To
ensure evidence-based quality guidance and prompt response to global demand, WHO convened a WHO Health
Emergencies (WHE) Programme Ad-Hoc Experts Advisory Panel for Infection Prevention and Control, which is attended
by members of the Global Infection Prevention and Control Network (GIPCN), members of relevant institutions, and
Member States affected by COVID-19. This advisory panel supports the WHE IPC pillar with timely advice on
preparedness, readiness and response to COVID-19 based on evidence where available. They hold weekly discussions
on the technical aspects of IPC measures, and shared experiences across affected countries. The following
guidance/tools have been issued, in consultation with this global IPC advisory panel:
1. Health workers exposure risk assessment and management in the context of COVID-19 virus. This tool is to
be used by health care facilities that have either cared for or admitted COVID-19 patients; it is to be
completed for all health care workers (HCW) who have been exposed to a confirmed COVID-19 patient in a
health care facility. It helps determine the risk of COVID-19 virus infection of the HCW who have been
exposed to a COVID-19 patient and provides recommendations for appropriate management of these HCWs,
according to their infection risk.
2. Considerations for quarantine of individuals in the context of containment for coronavirus disease (COVID19) The purpose of this document is to offer guidance to Member States on quarantine measures for
individuals in the context of COVID-19. It is intended for those responsible for establishing local or national
policy for quarantine of individuals, and adherence to infection prevention and control measures in these
settings.
3. In collaboration with WASH colleagues including UNICEF, the team has developed a briefing on water,
sanitation, hygiene and waste management for COVID-19. More information can be found here.
WHO IPC specialists are currently supporting a number of countries and have been deployed to support the response
in cooperation with IPC teams in Italy and Iraq, amongst other countries.
The online course “Infection Prevention and Control (IPC) for COVID-19” has been translated into Russian and
Japanese. As of 13 March, 38 725 people have registered for the course. Infographics, including videos (e.g. when and
how to use a mask), are being developed on demand,
To support the preparedness, readiness and response for COVID-19, WHO has convened teleconferences in
cooperation with other partners, including with Africa CDC/CDC/ECHO and with the World Organization of Family

Fresh Coffee

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec mattis pulvinar 

Play Video

Our Sweets Collection

The best way to experience our wide collection of sweets is to visit the store. Follow the aromas and choose the most enticing sweets to satisfy your palate.

Visit Us

  • 1123 4rd St. San Francisco, CA 66507
  • reservation@domain.com
  • (315) 435 77 16
  • (315) 435 77 33